Prof. MURAT TUNCEL

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Unexpected Axillary Lymph Node Uptake During Lower-Limb Lymphoscintigraphy in a Case With Vulvar Lymphangioma Circumscriptum

SOYDAŞ TURAN B., TUNCEL M.

Clinical nuclear medicine , vol.48, no.10, pp.879-880, 2023 (SCI-Expanded)

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer

von Eyben R., Hoffmann M. A., SOYDAL Ç., Virgolini I., TUNCEL M., Gauthé M., et al.

Biomedicines , vol.11, no.9, 2023 (SCI-Expanded)

Evaluation of efficacy of tumor-specific nanoliposomal radiosensitizer in radiotherapy

Karabuga M., ERDOĞAN S., Filikci K., Hazıroglu R., TUNCEL M., CENGİZ M.

Journal of Drug Delivery Science and Technology , vol.86, 2023 (SCI-Expanded)

Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer.

Petranović Ovčariček P., Campenni A., de Keizer B., Deandreis D., Kreissl M. C., Vrachimis A., et al.

Cancers , vol.15, no.17, 2023 (SCI-Expanded)

Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer.

Giovanella L., Milan L., Roll W., Weber M., Schenke S., Kreissl M., et al.

European journal of nuclear medicine and molecular imaging , vol.50, no.9, pp.2767-2774, 2023 (SCI-Expanded)

Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with Lu-177-PSMA-617. A single-center prospective observational study

Telli T., Tuncel M., Karabulut E., Aksoy S., Erman M., Akdogan B., et al.

PROSTATE , vol.83, no.8, pp.792-800, 2023 (SCI-Expanded)

Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with (177) Lu-PSMA-617. A single-center prospective observational study.

Telli T., Tuncel M., Karabulut E., Aksoy S., Erman M., Akdogan B., et al.

The Prostate , vol.83, pp.792-800, 2023 (SCI-Expanded) Sustainable Development

Quality Goal for Salvage Treatment for Patients with Prostate Cancer at Prostate-specific Antigen Relapse.

von Eyben R., Hoffmann M. A., Kapp D. S., Soydal C., Uprimny C., Virgolini I., et al.

European urology oncology , vol.5, pp.732-733, 2022 (SCI-Expanded) Sustainable Development

A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis.

von Eyben R., Kapp D. S., Hoffmann M. A., Soydal C., Uprimny C., Virgolini I., et al.

Cancers , vol.14, no.21, 2022 (SCI-Expanded)

SNMMI/EANM practice guideline vs. ETA Consensus Statement: differences and similarities in approaching differentiated thyroid cancer management-the EANM perspective

Ovcaricek P. P., Kreissl M. C., Campenni A., de Keizer B., Tuncel M., Vrachimis A., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.49, no.12, pp.3959-3963, 2022 (SCI-Expanded)

Diagnostic Performance of(99)mTc-methoxy-isobutyl-isonitrile (MIBI) Imaging in Hypofunctioning Thyroid Nodules: A European Multicenter Study

Schenke S., Campenni A., Tuncel M., Piccardo A., Sager S., Crncic T. B., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.49, no.SUPPL 1, 2022 (SCI-Expanded)

To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment.

Tuncel M., Vrachimis A., Campenni A., de Keizer B., Verburg F. A., Kreissl M. C., et al.

European journal of nuclear medicine and molecular imaging , vol.49, no.10, pp.3316-3319, 2022 (SCI-Expanded)

Diagnostic Performance of Tc-99m-Methoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules: A European Multicenter Study

Schenke S. A., Campenni A., TUNCEL M., Bottoni G., Sager S., Bogovic Crncic T., et al.

DIAGNOSTICS , vol.12, no.6, 2022 (SCI-Expanded)

Role of indocyanine green combined with radiotracer-Technetium 99 m in neck surgery for primary and recurrent head and neck cancer: preliminary results of a tertiary cancer center

Suslu N. S., KATAR O., TUNCEL M.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , vol.279, no.3, pp.1549-1560, 2022 (SCI-Expanded) Sustainable Development

18F FDG PET/CT after Neoadjuvant Chemotherapy and Pathological Responses are Predictive Factors for Disease-Free Survival and Overall Survival in Patients with Locally Advanced Breast Cancer: A Prospective Study

Kupik O., TUNCEL M., AKSOY S., Kiratli P. O., GÜLSÜN AKPINAR M., Altundag K., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.32, no.3, pp.150-158, 2022 (SCI-Expanded)

68Ga-DOTATATE PET/CT in Pituitary Carcinoma.

Kaya G., Soydas Turan B., Dagdelen S., Berker M., Tuncel M.

Clinical nuclear medicine , vol.46, pp.996-998, 2021 (SCI-Expanded)

Treatment of Glucagonoma-Related Necrolytic Migratory Erythema With Peptide Receptor Radionuclide Therapy.

Mavi M. E., Tuncel M.

Clinical nuclear medicine , vol.46, pp.1002-1003, 2021 (SCI-Expanded)

A multicenter survey of current practices of Tc-99m-methoxy-isobutyl-isonitrile (MIBI) imaging for the diagnosis of thyroid nodules: more standardization is essential

Schenke S. A., Campenni A., TUNCEL M., Piccardo A., Sager S., Crncic T. B., et al.

CLINICAL AND TRANSLATIONAL IMAGING , vol.9, no.5, pp.413-422, 2021 (SCI-Expanded)

Clinical parameters and nomograms for predicting lymphnode metastasis detected with 68Ga-PSMA-PET/CT

Onal C., Ozyigit G., Oymak E., Guler O. C., Hurmuz P., Tilki B., et al.

RADIOTHERAPY AND ONCOLOGY , vol.161, 2021 (SCI-Expanded)

Clinical parameters and nomograms for predicting lymph node metastasis detected with <sup>68</sup> Ga-PSMA-PET/CT in prostate cancer patients candidate to definitive radiotherapy.

Onal C., Ozyigit G., Oymak E., Guler O. C., Hurmuz P., Tilki B., et al.

The Prostate , vol.81, pp.648-656, 2021 (SCI-Expanded) Sustainable Development

Predictive factors of tumor sink effect: Insights from Lu-177-Prostate-specific membrane antigen therapy

TUNCEL M., TELLİ T., ÇAĞLAR TUNCALI M., KARABULUT E.

ANNALS OF NUCLEAR MEDICINE , vol.35, no.5, pp.529-539, 2021 (SCI-Expanded) Sustainable Development

Colonic Visualization of Tc-99m-DMSA Due to Enterovesical Fistula

TELLİ T., KAYA G., IŞIK Z., TUNCEL M.

CLINICAL NUCLEAR MEDICINE , vol.46, no.1, pp.66-68, 2021 (SCI-Expanded)

Diagnostic and therapeutic evaluation of folate-targeted paclitaxel and vinorelbine encapsulating theranostic liposomes for non-small cell lung cancer

Karpuz M., Silindir-Gunay M., Ozer A. Y., Ozturk S. C., Yanik H., Tuncel M., et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.156, 2021 (SCI-Expanded) Sustainable Development

Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT

ÇAĞLAR TUNCALI M., TUNCEL M., Yildiz E., KARABULUT E.

ANNALS OF NUCLEAR MEDICINE , vol.34, no.12, pp.932-941, 2020 (SCI-Expanded) Sustainable Development

The role of Tc-99m MIBI scintigraphy in clinical T1 renal mass assessment: Does it have a real benefit?

Asi T., Tuncali M., Tuncel M., Alkanat N., Hazir B., Kösemehmetoğlu K., et al.

Urologic oncology , vol.38, 2020 (SCI-Expanded)

Interpreting Clinical Parameters and Nomograms for Predicting Lymph Node Metastasis Detected with 68Ga-PSMA-PET/CT in prostate cancer patients

Önal C., Özyiğit G., Oymak E., Güler O. C., Hürmüz P., Tilki B., et al.

International Journal Of Radiation Oncology Biology Physics , vol.3, no.108, pp.895, 2020 (SCI-Expanded) Sustainable Development

Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients

Onal C., Ozyigit G., Cem G., Hurmuz P., Torun N., Tuncel M., et al.

RADIOTHERAPY AND ONCOLOGY , vol.151, pp.222-227, 2020 (SCI-Expanded) Sustainable Development

Clinical Impact of PET Imaging in Patients With Metastatic Prostate Cancer.

Tuncel M., Tuncalı M., Telli T., Erman M.

Clinical nuclear medicine , vol.45, pp.757-764, 2020 (SCI-Expanded)

Clinical impact of <sup>68</sup>Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer.

Tuncel M., Kılıçkap S., Süslü N.

Annals of nuclear medicine , vol.34, pp.663-674, 2020 (SCI-Expanded) Sustainable Development

Comparison of clinical and PET-derived prognostic factors in patients with non-Hodgkin lymphoma: a special emphasis on bone marrow involvement

Kupik O., Akin S., Tuncel M., Eren G., Türker A., Kars A., et al.

NUCLEAR MEDICINE COMMUNICATIONS , vol.41, no.6, pp.540-549, 2020 (SCI-Expanded)

Using a pessary during radiotherapy in reducible pelvic organ prolapse and vaginal cancer: a case report and review of the literature

GÜLTEKİN M., Esen C. S. B., AKGÖR U., SALMAN M. C., TUNCEL M., Ozmen M., et al.

JOURNAL OF CONTEMPORARY BRACHYTHERAPY , vol.12, no.2, pp.175-180, 2020 (SCI-Expanded)

Thyroid volumes and serum VEGF levels in dyslipidemic patients: effects of statin treatment

Aydın K., Ersöz G., Tuncel M., Balcı C., Akın Ş., Çınar N., et al.

Turkish journal of medical sciences , vol.49, pp.738-745, 2019 (SCI-Expanded)

Radioguided occult lesion localization in patients with recurrent thyroid cancer.

Tuncel M., Süslü N.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery , vol.276, pp.1757-1766, 2019 (SCI-Expanded) Sustainable Development

Ga-68-labelled PSMA ligand HBED-CC PET/CT imaging in patients with recurrent prostate cancer

AKDEMİR E., TUNCEL M., AKYOL H. F., BİLEN C. Y., Baydar D. E., KARABULUT E., et al.

WORLD JOURNAL OF UROLOGY , vol.37, no.5, pp.813-821, 2019 (SCI-Expanded) Sustainable Development

Radiolabeled, folate-conjugated liposomes as tumor imaging agents: Formulation and in vitro evaluation

Silindir-Gunay M., KARPUZ M., Ozturk N., Yekta Ozer A., ERDOĞAN S., TUNCEL M.

Journal of Drug Delivery Science and Technology , vol.50, pp.321-328, 2019 (SCI-Expanded)

Value of post-therapy 177Lu-PSMA images for accurate interpretation of therapy response with 68Ga-PSMA PET/CT Valor de las imágenes de 177Lu-PSMA post-terapia para una interpretación precisa de la respuesta a la terapia con PET/TC con 68Ga-PSMA

TUNCEL M., TELLİ T.

Revista Espanola de Medicina Nuclear e Imagen Molecular , vol.37, no.2, pp.114-117, 2018 (SCI-Expanded)

Effectiveness of Radioisotype Synoviectomy in Haemophilia Patients With High Titer Inhibitors

AYTAÇ S. A., Bajin I. Y., Altan I., TUNCEL M., ÇAĞLAR Ö., ÇETİN M., et al.

HAEMOPHILIA , vol.23, pp.129-130, 2017 (SCI-Expanded)

Prognosis estimation under the light of metabolic tumor parameters on initial FDG-PET/CT in patients with primary extranodal lymphoma

OKUYUCU K., OZAYDLN S., Alagoz E., OZGUR G., INCE S., OYSUL F. G., et al.

Radiology and Oncology , vol.50, no.4, pp.360-369, 2016 (SCI-Expanded)

Results of intraoperative gamma probe survey and frozen section in surgical treatment of parathyroid adenoma in children

SOYER T., KARNAK İ., TUNCEL M., EKİNCİ S., Andiran F., ÇİFTÇİ A. Ö., et al.

JOURNAL OF PEDIATRIC SURGERY , vol.51, no.9, pp.1492-1495, 2016 (SCI-Expanded)

Renal Function Assessment During Peptide Receptor Radionuclide Therapy

Erbas B., TUNCEL M.

SEMINARS IN NUCLEAR MEDICINE , vol.46, no.5, pp.462-478, 2016 (SCI-Expanded) Sustainable Development

Nuclear Medicine in Pediatric and Adolescent Tumors

Kiratli P. O., TUNCEL M., bar-sever Z.

SEMINARS IN NUCLEAR MEDICINE , vol.46, no.4, pp.308-323, 2016 (SCI-Expanded) Sustainable Development

Clinical impact of SPECT-CT on bone scintigraphy in oncology: Pattern approach.

Tuncel M., Lay E., Caglar T.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.21, pp.1296-1306, 2016 (SCI-Expanded)

Comparison of wire-guided localization and radio-guided occult lesion localization in preoperative localization of nonpalpable breast lesions

Kanat N. B., TUNCEL M., Aksoy T., FIRAT A., DEMİRKAZIK F., Onat D., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.46, no.6, pp.1829-1837, 2016 (SCI-Expanded)

Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT

Silindir M., Erdoğan S., Özer A. Y., Doğan A. L., Tuncel M., Uğur Ö., et al.

JOURNAL OF LIPOSOME RESEARCH , vol.23, no.1, pp.20-27, 2013 (SCI-Expanded) Sustainable Development

Changing clinical characteristics of thyroid carcinoma at a single center from Turkey: before and after the Chernobyl disaster

Özdemir D. M., Dağdelen S., Kıratlı P., Tuncel M., Erbas B., Erbas T.

MINERVA ENDOCRINOLOGICA , vol.32, no.3, pp.267-274, 2012 (SCI-Expanded)

Osteopoikilosis: a major diagnostic problem solved by bone scintigraphy

TUNCEL M., Caner B.

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , vol.31, no.2, pp.93-96, 2012 (SCI-Expanded)

99mTc-MDP uptake in thyroid nodule: contribution of SPECT-CT and ultrasonography.

Tuncel M., Akdemir E.

Revista espanola de medicina nuclear e imagen molecular , vol.31, pp.49-50, 2012 (SCI-Expanded)

SPECT-CT imaging of poliostotic fibrous dysplasia.

Tuncel M., Kiratli P., Gedikoglu G.

Revista espanola de medicina nuclear e imagen molecular , vol.31, pp.47-8, 2012 (SCI-Expanded) Sustainable Development

The value of SPECT-CT in the calculation of post-operative FEV1 value: Preliminary results

TUNCEL M., Kiratli P. O.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.38, 2011 (SCI-Expanded)

Clinical Impact of SPECT-CT on Bone Scintigraphy in Oncology: Pattern Approach

TUNCEL M., ERGÜN E., Tuncali M. C.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.38, 2011 (SCI-Expanded)

Gastroesophageal reflux scintigraphy: interpretation methods and inter-reader agreement.

Tuncel M., Kıratlı P., Aksoy T., Bozkurt M.

World journal of pediatrics : WJP , vol.7, pp.245-9, 2011 (SCI-Expanded)

Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography in patients with small cell lung cancer

Arslan N., Tuncel M., Kuzhan O., Alagoz E., Budakoglu B., Ozet A., et al.

ANNALS OF NUCLEAR MEDICINE , vol.25, no.6, pp.406-413, 2011 (SCI-Expanded) Sustainable Development

The value of SPECT-CT in the post I-131 ablation evaluation of patients with thyroid cancer

TUNCEL M., Vatankulu B., Caglar M.

JOURNAL OF NUCLEAR MEDICINE , vol.52, 2011 (SCI-Expanded) Sustainable Development

Butterfly vertebra: a diagnostic pitfall on bone scintigraphy.

Tuncel M., Topbasi Z., Kiratli P.

Clinical nuclear medicine , vol.35, pp.293-4, 2010 (SCI-Expanded)

Simultaneous Anterior-Posterior Dynamic Renal Scintigraphy for the Evaluation of Congenital Abnormal Kidneys

ERGÜN E., TUNCEL M., BOZKURT M. F., Caner B.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.29, no.1, pp.155-161, 2009 (SCI-Expanded)

The Clinical Features Of The Tall Cell Variant Of Papillary Thyroid Carcinoma

Alagoz E., Arslan N., Ilgan S., Karacalioglu A. O., Emer O., Ayan A., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.35, 2008 (SCI-Expanded)

Gated MPS in Children with Myocarditis: Can it be Considered as an Indicator of Clinical Outcome?

Kiratli P., TUNCEL M., Caglar M., Ozkutlu S.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.35, 2008 (SCI-Expanded)

Gated myocardial perfusion scintigraphy in children with myocarditis: can it be considered as an indicator of clinical outcome?

Kiratli P., Tuncel M., Ozkutlu S., Caglar M.

Nuclear medicine communications , vol.29, pp.907-14, 2008 (SCI-Expanded)

[C-11]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer

Tuncel M., Souvatzoglou M., Herrman K., Stollfuss J., Schuster T., Weirich G., et al.

NUCLEAR MEDICINE AND BIOLOGY , vol.35, no.6, pp.689-695, 2008 (SCI-Expanded) Sustainable Development

Efficacy of 11C-Choline PET/CT for detection of recurrence in patients with rising PSA after radical prostatectomy

Treiber U., Souvatzoglou M., Tuncel M., Maurer T., Kuebler H., Zantl N., et al.

EUROPEAN UROLOGY SUPPLEMENTS , vol.7, no.3, pp.284, 2008 (SCI-Expanded)

The detection rate of [C-11]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer

Krause B. J., Souvatzoglou M., Tuncel M., Herrmann K., Buck A. K., Praus C., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.35, no.1, pp.18-23, 2008 (SCI-Expanded) Sustainable Development

Diagnostic accuracy of F-18-FDG PET/CT in characterizing ovarian lesions

Tuncel M.

NUCLEAR MEDICINE COMMUNICATIONS , vol.28, no.11, pp.879-880, 2007 (SCI-Expanded)

Vascular retention of Tc-99m pertechnetate and Tc-99m sestamibi, mimicking thyroid carcinoma metastases.

Tuncel M., Ozgen K.

Revista espanola de medicina nuclear , vol.26, pp.226-9, 2007 (SCI-Expanded)

The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake

Tuncel M., Aydin D., Yaman E., Tazebay U. H., Guc D., Dogan A. L., et al.

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , vol.22, no.2, pp.281-288, 2007 (SCI-Expanded) Sustainable Development

How much CT do we need in C-11-Choline PET/CT in patients suffering from prostate cancer with suspicion of bone metastases?

Tuncel M., Souvatzoglou M., Herrman K., Stollfuss J., Schwaiger M., Krause B. J.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.33, 2006 (SCI-Expanded) Sustainable Development

The influence of the PSA value on the sensitivity of C-11-Choline PET/CT in restaging patients with recurrent prostate cancer

Tuncel M., Souvatzoglou M., Herrmann K., Busch R., Stollfuss J., Schwaiger M., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.33, 2006 (SCI-Expanded) Sustainable Development

The value of 11C-Choline PET/CT versus 11C-Choline PET in the evaluation of patients with prostate cancer with suspicion of bone metastases

Souvatzoglou M., Tuncel M., Herrman K., Stollfuss J., Schwaiger M., Krause B. J.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.33, 2006 (SCI-Expanded)

The comparative effects of gene modulators on thyroid specific genes and radioiodine uptake

Tuncel M., Aydin D., Cankaya E. Y., Tazebay U. H., Guc D., Dogan A. L., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.33, 2006 (SCI-Expanded)

The comparative effects of gene modulators on thyroid specific genes and radioiodine uptake

Tuncel M., Aydin D., Cankaya E. Y., Tazebay U. H., Guc D., Dogan A. L., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.33, 2006 (SCI-Expanded)

Behcet disease with an intrapulmonary shunt.

Tuncel M., Kiratli P., Mahmoudian B.

Clinical nuclear medicine , vol.31, pp.181-2, 2006 (SCI-Expanded)

Value of hepatobiliary scintigraphy after type 1 choledochal cyst excision and Roux-en-y hepatojejunostomy

Tuncel M., Ergün E.

Clinical Nuclear Medicine , vol.31, no.2, pp.93-95, 2006 (SCI-Expanded)

Scintigraphic imaging of radiolabelled drug delivery systems in rabbits with arthritis

Turker S., Erdogan S., Ozer Z., Ergun E., Tuncel M., Bilgili H., et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.296, no.1-2, pp.34-43, 2005 (SCI-Expanded)

Value of technetium scintigraphy and iodine uptake measurement during follow-up of differentiated thyroid cancer.

Caglar M., Tuncel M., Alpar R.

Annals of nuclear medicine , vol.18, pp.479-82, 2004 (SCI-Expanded) Sustainable Development

Selected intra-arterial injection of Tc-99m MDP.

Mahmoudian B., Ozgen K., Tuncel M., Bozkurt F.

Revista espanola de medicina nuclear , vol.23, pp.284-5, 2004 (SCI-Expanded)

Increased uptake on I-131 whole-body scintigraphy in Warthin tumor despite false-negative Tc-99m pertechnetate salivary gland scintigraphy.

Caglar M., Tuncel M., Usubutun A.

Clinical nuclear medicine , vol.28, pp.945-6, 2003 (SCI-Expanded)

Gamut: soft tissue uptake of bone radiopharmaceuticals.

Tuncel M., Erbas B., Mahmoudian B.

Seminars in nuclear medicine , vol.33, pp.334-7, 2003 (SCI-Expanded)

Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment

Caglar M., Tuncel M., Alpar R.

CLINICAL NUCLEAR MEDICINE , vol.27, no.11, pp.767-771, 2002 (SCI-Expanded) Sustainable Development

Osteoid osteoma of the rib detected on bone scintigraphy: importance of pattern recognition.

Tuncel M., Caglar M.

Clinical nuclear medicine , vol.27, pp.216-7, 2002 (SCI-Expanded)

Articles Published in Other Journals

Molecular Pathological Markers and TERT Promoter Mutations: Correlations with Clinicopathological Features and Distant Metastasis in Turkish Patients with Papillary Thyroid Carcinoma

YILMAZ E., Güler G., KURTULAN O., Karakaya J., TELLİ T., TUNCEL M., et al.

Endocrinology Research and Practice , vol.27, no.4, pp.191-198, 2023 (Scopus)

Value of Dynamic (18)F-FDG PET/CT in Predicting the Success of Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer: A Prospective Study.

Kupik O., Tuncel M., Özgen Kıratlı P., Akpınar M. G., Altundağ K., Başaran Demirkazık F., et al.

Molecular imaging and radionuclide therapy , vol.32, no.2, pp.94-102, 2023 (Scopus)

FDG-PET/CT Imaging of Large Vessel Vasculitis

Kaya G., Tuncel M.

Acta Medica , vol.53, pp.37-44, 2022 (Peer-Reviewed Journal)

Cerebellar Hypermetabolism: An Alternative Marker for Diagnosis of Paraneoplastic Cerebellar Degeneration.

Arslan D., Ardıc F. S., Gultekin-Zaim O. B., Tuncel M., Kertmen N., Gocmen R., et al.

Neurologia (Barcelona, Spain) , 2022 (Peer-Reviewed Journal)

Predictive Value of Dual-phase F-18-FDG PET/CT in the Assessment of Neoadjuvant Chemotherapy Response in Patients with Locally Advanced Breast Cancer: A prospective Comparative Study with Dynamic Contrast-enhanced Magnetic Resonance Imaging

Kupik O., TUNCEL M., Kiratli P. O., GÜLSÜN AKPINAR M., Altundag K., DEMİRKAZIK F., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.37, pp.426-435, 2022 (ESCI)

Non-ultrasonographic and Non-radioiodine Imaging Techniques in Thyroid Cancer

TUNCEL M.

NUCLEAR MEDICINE SEMINARS , vol.7, 2021 (Peer-Reviewed Journal)

Can surgical adhesives may cause false positivity in follow-up positron emission tomography after lung cancer resection? Cerrahi doku yapıştırıcılar akciğer kanseri rezeksiyonu sonrası takip pozitron emisyon tomografisinde yanlış pozitifliğe neden olur mu?

Doğan R., Uysal S., Kumbasar U., Köksal D., Ancın B., Tuncel M.

Tuberkuloz ve Toraks , vol.69, no.1, pp.59-64, 2021 (ESCI)

Stereotactic ablative radiotherapy for bone metastasis of gastrointestinal stromal tumor: Case report and review of the literature

YILMAZ M. T., GÜLTEKİN M., YALÇIN Ş., TUNCEL M., Gedikoglu G., YILDIZ F., et al.

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY , vol.25, no.3, pp.331-335, 2020 (ESCI)

Critical Role of Ga-68 DOTATATE PET-CT in a Patient with Neuroendocrine Tumor and Second Primary Cancer

TELLİ T., TUNCEL M., KILIÇKAP S.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , vol.23, no.1, pp.58-63, 2019 (ESCI) Sustainable Development

Thyroid stimulating hormone receptor Tiroid Stimulan Hormon Reseptörü

TUNCEL M.

Molecular Imaging and Radionuclide Therapy , vol.26, pp.87-91, 2017 (Scopus)

Symptomatic Adrenal Insufficiency due to Bilateral Adrenal Non-Hodgkin’s Lymphoma

AKIN Ş., Akın S., TUNCEL M., ERSÖZ G. N.

Turkish Journal of Endocrinology and Metabolism , vol.20, pp.108-110, 2016 (Scopus)

Refereed Congress / Symposium Publications in Proceedings

Radiolabelling of Gallium-68 DTPA and EDTA used for Kidney Imaging

- Molaei A., SARCAN BOZKIR E. T., ERDOĞAN S., TUNCEL M.

International Multidisciplinary Symposium on Drug Research and Development (DRD) 2023, İzmir, Turkey, 04 May 2023

Clinical Significance of Bayesian penalized-likelihood and Motion Correction PET Reconstruction Algorithms

Kaya G., Pala H., Tuncel M., Uğur Ö.

Annual Congress of the European Association of Nuclear Medicine October 15-19, 2022 Barcelona, Spain, Barcelona, Spain, 15 - 19 October 2022, pp.163

Do ultrasound elastography and thyroid imaging reporting and data systems correctly classify hyperfunctioning nodules on thyroid scintigraphy?

Tuncel M., Turan B. S., Isik Z.

vol.48

Factors that could predict tumour sink effect: Experience with Lu177 Prostatespecific membrane antigen therapy

Tuncel M., Telli T., Tuncali M., Karabulut E.

vol.48

Interpreting Clinical Parameters and Nomograms for Predicting Lymph Node Metastasis Detected with 68 Ga-PSMAPET/CT in prostate cancer patients

Onal C., Ozyigit G., Oymak E., Guler O. C., Hurmuz P., Tilki B., et al.

62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 25 - 28 October 2020, vol.108 Sustainable Development

Interpreting Clinical Parameters and Nomograms for Predicting Lymph Node Metastasis Detected with 68 Ga-PSMAPET/CT in prostate cancer patients

ÖNAL H. C., ÖZYİĞİT G., Oymak E., GÜLER O. C., HÜRMÜZ P., TİLKİ B., et al.

62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), 25 October - 28 December 2020 Sustainable Development

Efficacy of Lu-177-PSMA-617 Therapy in Metastatic Castration-resistant Prostate Cancer Patients, A Single-Center Experience

Telli T., Tuncel M., Caglar M.

33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), ELECTR NETWORK, 22 - 30 October 2020, vol.47 Sustainable Development

Is It Safe Enough to Follow-up Patients Only with Post-therapy Whole-body Scan After PRRT?

Telli T., Tuncel M., Kiratli P. O.

33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), ELECTR NETWORK, 22 - 30 October 2020, vol.47

Clinical Impact Of [Ga-68]Ga-DOTA-TATE Imaging In Patients With Medullary Thyroid Cancer

Tuncel M., Kilickap S., Suslu N.

33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), ELECTR NETWORK, 22 - 30 October 2020, vol.47 Sustainable Development

Predictors of Intertumoral Heterogeneity of F-18-FDG and Ga-68-PSMA Uptake in Patients with Prostate Cancer

Telli T., Tuncel M., Caglar M.

33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), ELECTR NETWORK, 22 - 30 October 2020, vol.47 Sustainable Development

In vitro and In vivo Diagnostic and Therapeutic Evaluation of Folate-Targeted, Paclitaxel and Vinorelbine Encapsulated Theranostıc Liposomes in Non-Small Cell Lung Cancer

Karpuz M., Silindir Günay M., Öztürk S. C., Yanık H., Tuncel M., Esendağlı G., et al.

8th BBBB International Conference on Pharmaceutical Sciences, İzmir, Turkey, 13 - 16 October 2019, pp.90-91 Sustainable Development

How accurate is serum thyroglobulin measurement in patients with differentiated thyroid cancer?

TUNCEL M., TELLİ T., Tuncali M. C.

32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, Spain, 12 - 16 October 2019, vol.46 Sustainable Development

The Role of (68)ga-PSMA-PET/CT in Pelvic FIELD Delineation in Prostate Cancer Patients with Pelvic Lymph Node Metastasis

Onal C., HÜRMÜZ P., Torun N., TUNCEL M., Guler O. C., Reyhan M., et al.

61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Illinois, United States Of America, 15 - 18 September 2019, vol.105

Integration of (68)ga-PSMA-PET/BT in Radiation Therapy Planning for Prostate Cancer Patients: A Multi-Institutional Analysis

Onal C., Torun N., HÜRMÜZ P., Guler O. C., TUNCEL M., Yildirim B. A., et al.

60th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Northern Mariana Islands, 21 - 24 October 2018, vol.102

Slowly progressive disease a new therapy response criteria? Lessons from tyrosine kinase inhibitor therapy

TUNCEL M.

88th Annual Meeting of the American Thyroid Association, Washington, Kiribati, 03 October 2018 - 07 October 2108, vol.28

The Role of FDG PET/CT Detecting Bone Marrow Involvement in Non-Hodgkin's Lymphoma Patients

KUPIK O., Akin S., TUNCEL M., TÜRKER A., Kars A., Erbas B.

31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Düsseldorf, Germany, 13 - 17 October 2018, vol.45

Yavaş büyüyen soliter pulmoner nodül: Adenoleiomyomatöz Hamartom

BABAOĞLU E., SARINÇ ULAŞLI S., ÖNDER S. Ç., TUNCEL M., KÖKSAL D.

Ulusal Akciğer Sağlığı KOngresi, Turkey, 14 - 18 March 2018

FDG PET-CT parameters in the therapy evaluation of patients with Hodgkin's lymphoma

TUNCEL M., Kutluk T. M., Kiratli P. O., AYDIN B., Erbas B., AKYÜZ C.

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, Spain, 15 - 19 October 2016, vol.43

Tuncel M Kurucu N Kıratlı PÖ Erbaş B Akyüz C Clinical Impact of FDG PET CT in pediatric soft tissue sarcoma Eur J Nucl Med Mol Imaging

TUNCEL M., KURUCU N., ÖZGEN KIRATLI M. P., ERBAŞ H. B., AKYÜZ C.

Annual Congress of the European Association of the Nucleer Medicine, Hamburg, Germany, 10 - 14 October 2015, vol.42, pp.206